Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Myeloid Cells
100%
Phosphodiesterase Type 5 Inhibitors
100%
Tadalafil
100%
Antitumor Efficacy
40%
T Cell Activation
40%
Mesothelin
40%
Immunosuppressive Myeloid Cells
40%
Tumor Immune Microenvironment
40%
Tumor
20%
Inducible Nitric Oxide Synthase
20%
T Cells
20%
Interleukin-12 (IL-12)
20%
Intracellular Signaling
20%
Clinical Efficacy
20%
Head-and-neck Cancer
20%
Anti-tumor Response
20%
Cell Death
20%
Cell Activation
20%
Immunosuppressive Agents
20%
Specific T Cells
20%
Inflammatory State
20%
CXCR3
20%
Metabolic Regulators
20%
Arginase
20%
Patient Experience
20%
T Cell Signaling
20%
Checkpoint Inhibitors
20%
T Cell Inhibition
20%
Immune Recognition
20%
Anti-cytotoxic
20%
Signaling Axis
20%
Domino
20%
Cellular Crosstalk
20%
Mass Cytometry
20%
Single-cell RNA Sequencing Analysis
20%
Medicine and Dentistry
Immunotherapy
100%
Pancreas Adenocarcinoma
100%
Phosphodiesterase V
100%
Myeloid Cell
100%
Tadalafil
100%
T Cell
80%
Immunosuppressive Drug
60%
Immunity
60%
Mesothelin
40%
Tumor Immune Microenvironment
40%
Neoplasm
20%
Head and Neck Cancer
20%
Cell Death
20%
RNA Sequence
20%
Synapsin I
20%
Antigen Recognition
20%
Patient Experience
20%
T Cell Activation
20%
Phosphodiesterase V Inhibitor
20%
Arginase
20%
Cell Activation
20%
T-Cell Signaling
20%
Mass Cytometry
20%
Immunology and Microbiology
Immunotherapy
100%
Myeloid
100%
Immunity
71%
T Cell
57%
Immunosuppressive Drug
42%
Mesothelin
28%
Cell Activation
14%
Neck
14%
T Cell Activation
14%
Cell Death
14%
Antigen Recognition
14%
RNA Sequence
14%
T-Cell Signaling
14%
Mass Cytometry
14%